Large Employers Warm Up To Point-of-Sale Rebates

August 27

As the debate continues over the merits of overhauling the prescription drug rebate system, large employers — which traditionally have retained drug discounts that PBMs negotiate with manufacturers — appear to be searching for a different way forward.

“Employers struggle to reconcile the role of manufacturer rebates in pharmacy benefit management. With no meaningful alternatives to the rebate-driven contracting model, large employers have continued to implement point-of-sale (POS) rebate programs,” stated the Business Group on Health’s 2021 Large Employers’ Health Care Strategy and Plan Design Survey.

0 Comments

Radar on Drug Benefits

Leslie Small

Leslie has been working in journalism since 2009 and reporting on the health care industry since 2014. She has covered the many ups and downs of the Affordable Care Act exchanges, the failed health insurer mega-mergers, and hundreds of other storylines spanning subjects such as Medicaid managed care, Medicare Advantage, employer-sponsored insurance, and prescription drug coverage. As the managing editor of Health Plan Weekly and Radar on Drug Benefits, she writes and edits for both publications while overseeing a small team of reporters who also focus on the managed care sector. Before joining AIS Health, she was a senior editor for the e-newsletter Fierce Health Payer, and she started her career as a copy editor at multiple local newspapers. She graduated with a dual degree in journalism and political science from Penn State University.

Part D Base Beneficiary Premium Will Grow Slightly in 2021 August 27, 2020

UnitedHealth Drops Descovy as Generic Shakes Up PrEP Class August 27, 2020